Clinical Trial Update: Escitalopram in Treating Depression in Patients With Advanced Lung or Gastrointestinal Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating escitalopram for depression in patients with advanced lung or gastrointestinal cancer was terminated; results were posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Esophageal Cancer
• Gallbladder Cancer
• Gastric Cancer
• Liver Cancer
• Lung Cancer
• Major Depressive Disorder
• Pancreatic Cancer

Drugs mentioned

• Escitalopram (escitalopram)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Colorectal Cancer, Depression | Phase 3 | Status: TERMINATED | Results posted: 2012-12-03